ImmunityBio, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:IBRX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 382.93 M303.76 M402.08 M518.99 M501.9 M646.64 M 총 부채 871.06 M894.24 M971.89 M1.04 B1 B1.52 B 자본금 총액 -488.13 M-590.48 M-569.82 M-523.41 M-499.57 M-869.13 M 총 부채 및 주주자본 382.93 M303.76 M402.08 M518.99 M501.9 M646.64 M 총부채 284.4 M296.29 M307.1 M318.75 M326.37 M405.18 M 순부채 134.59 M234.7 M153.44 M60.94 M83.55 M24.3 M

뉴스

IBRX and the BCG Shortage: Deals That Could Expand Demand

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

Undercovered Stocks: Cerebras Systems, Infleqtion, Duos Technologies And More

FDA Accepts IBRX's Filing Seeking Expanded Use of Bladder Cancer Therapy

ImmunityBio Secures Five U.S. Patents for Anktiva in Bladder Cancer

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue Estimates

Why ImmunityBio Stock Is Surging On Wednesday? - ImmunityBio (NASDAQ:IBRX)

ImmunityBio to Report Q1 Earnings: What's in the Cards?

IBRX Global Rollout: EU, MENA, and Asia Shape 2026-27 Catalysts

Is IBRX Priced for Perfection at Nearly 28x Forward Sales?